Shares of ICON Public Limited (NASDAQ:ICLR – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the fifteen ratings firms that are covering the firm, Marketbeat reports. Three research analysts have rated the stock with a hold rating, eleven have issued a buy rating and one has assigned a strong buy rating to the company. The average 1-year target price among analysts that have issued ratings on the stock in the last year is $279.17.
Several equities analysts have recently commented on the company. Leerink Partners reaffirmed an “outperform” rating and issued a $255.00 price target (down previously from $270.00) on shares of ICON Public in a research note on Tuesday, November 19th. Citigroup lowered their target price on shares of ICON Public from $300.00 to $290.00 and set a “buy” rating for the company in a research note on Monday, January 6th. Royal Bank of Canada reiterated an “outperform” rating and set a $263.00 price target on shares of ICON Public in a research report on Wednesday, January 15th. Barclays decreased their price objective on shares of ICON Public from $275.00 to $240.00 and set an “overweight” rating on the stock in a report on Friday, February 21st. Finally, JPMorgan Chase & Co. dropped their target price on shares of ICON Public from $280.00 to $265.00 and set an “overweight” rating for the company in a report on Monday, February 3rd.
Check Out Our Latest Stock Report on ICLR
ICON Public Price Performance
ICON Public (NASDAQ:ICLR – Get Free Report) last released its quarterly earnings results on Wednesday, February 19th. The medical research company reported $3.42 EPS for the quarter, beating the consensus estimate of $3.41 by $0.01. The firm had revenue of $2.04 billion for the quarter, compared to analyst estimates of $2.04 billion. ICON Public had a net margin of 9.56% and a return on equity of 11.81%. Analysts predict that ICON Public will post 13.38 earnings per share for the current year.
Institutional Trading of ICON Public
Several hedge funds have recently modified their holdings of the stock. Natixis Advisors LLC grew its stake in ICON Public by 6.7% during the 4th quarter. Natixis Advisors LLC now owns 177,761 shares of the medical research company’s stock worth $37,279,000 after purchasing an additional 11,177 shares in the last quarter. State of Tennessee Department of Treasury raised its position in ICON Public by 1.0% in the 4th quarter. State of Tennessee Department of Treasury now owns 158,947 shares of the medical research company’s stock valued at $33,333,000 after purchasing an additional 1,600 shares in the last quarter. Kornitzer Capital Management Inc. KS boosted its stake in shares of ICON Public by 40.6% in the 4th quarter. Kornitzer Capital Management Inc. KS now owns 97,102 shares of the medical research company’s stock valued at $20,363,000 after buying an additional 28,050 shares during the period. Motley Fool Wealth Management LLC grew its position in shares of ICON Public by 2.3% during the fourth quarter. Motley Fool Wealth Management LLC now owns 64,038 shares of the medical research company’s stock worth $13,342,000 after buying an additional 1,466 shares in the last quarter. Finally, Foyston Gordon & Payne Inc increased its stake in shares of ICON Public by 27.3% during the fourth quarter. Foyston Gordon & Payne Inc now owns 51,713 shares of the medical research company’s stock worth $10,845,000 after buying an additional 11,089 shares during the period. 95.61% of the stock is currently owned by institutional investors and hedge funds.
ICON Public Company Profile
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies.
Read More
- Five stocks we like better than ICON Public
- What Are the FAANG Stocks and Are They Good Investments?
- Can TikTok Stock Picks Really Make You Rich?
- What is a Bond Market Holiday? How to Invest and Trade
- The “Quality” Rotation: Back to Basics Investing
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Occidental Petroleum: 4 Reasons to Love These Prices
Receive News & Ratings for ICON Public Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICON Public and related companies with MarketBeat.com's FREE daily email newsletter.